Voigt Michel J. 4
4 · MERIT MEDICAL SYSTEMS INC · Filed Mar 2, 2026
Research Summary
AI-generated summary of this filing
Merit Medical (MMSI) CHRO Michel Voigt Receives RSU Awards, Surrenders Shares
What Happened
Michel J. Voigt, Chief Human Resources Officer of Merit Medical Systems (MMSI), was granted three awards of restricted stock units (RSUs) totaling 31,101 RSUs (7,690; 6,409; and 17,002 shares) on 2026-02-26 (recorded as acquisitions at $0.00). On the same date he surrendered 6,698 shares of common stock to the company to satisfy payroll and income tax withholding obligations; those shares were treated as a disposition at $78.02 per share, totaling $522,578. No open-market sale occurred — the shares were surrendered to the issuer for taxes.
Key Details
- Transaction date(s): 2026-02-26; Form filed 2026-03-02 (timely within SEC reporting window).
- Awards: 7,690 RSUs; 6,409 RSUs; 17,002 RSUs — total 31,101 RSUs granted (reported as acquisitions at $0.00).
- Tax withholding: 6,698 shares surrendered at $78.02/share = $522,578 (disposition code F). Filing notes that shares were surrendered for payroll and income taxes, not sold in the market.
- Vesting/conditions: RSUs generally vest over multi-year schedules (see footnotes) — some RSUs vest in three equal annual installments, others in two; separate performance stock units from 02/28/2023 were issued after committee determination.
- Shares owned after transaction: filing references plan holdings as of 02/26/2026 but does not state a total combined post-transaction common stock holding in the Form 4.
- Transaction codes: A = Award/Grant; F = Tax withholding (not a market sale).
Context
- These are awards (RSUs and performance-based shares), not open-market purchases or sales that would indicate immediate trading sentiment. The surrender of shares was purely to satisfy tax withholding on the awards (a common administrative action).
- For retail investors, awards increase potential future share dilution as RSUs vest, while the tax-surrender is routine and does not reflect a decision to liquidate holdings on the market.
Insider Transaction Report
- Award
Common Stock, No Par Value
[F2]2026-02-26+7,690→ 29,414 total - Award
Common Stock, No Par Value
[F3]2026-02-26+6,409→ 35,823 total - Award
Common Stock, No Par Value
[F4]2026-02-26+17,002→ 52,825 total - Tax Payment
Common Stock, No Par Value
[F5]2026-02-26$78.02/sh−6,698$522,578→ 46,127 total
- 15(indirect: By 401(k))
Common Stock, No Par Value
[F1] - 2,420
Non-qualified stock options (right to buy)
[F6]Exercise: $56.25From: 2022-03-19Exp: 2028-03-19→ Common Stock (2,420 underlying) - 4,046
Non-qualified stock options (right to buy)
[F7]Exercise: $65.03From: 2023-02-28Exp: 2029-02-28→ Common Stock (4,046 underlying) - 11,076
Non-qualified stock options (right to buy)
[F8]Exercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (11,076 underlying)
Footnotes (8)
- [F1]Represents plan holdings as of 02/26/2026.
- [F2]Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
- [F3]Represents a grant of RSUs. The RSUs vest in two equal installments on each of the second and the third anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
- [F4]These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/28/2023.
- [F5]The Reporting Person surrendered 6,698 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.
- [F6]Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
- [F7]Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
- [F8]Become exercisable in equal annual installments of 25% commencing on 02/28/2024.